DXCM DEXCOM INC.

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

(NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) systems for people with diabetes, is teaming up with from around the globe to help raise awareness for the need to improve access to life-changing diabetes technology during National Diabetes Awareness Month in the U.S. and Canada (November) and on World Diabetes Day (November 14).

This press release features multimedia. View the full release here:

Dexcom Warriors from top left to right: Bambi B., Enrrique A., Nenad Š., Qiana D. & Lily D., Nick J.
Dexcom Warriors from bottom left to right: Natalie B., Victor G., Patti L., Hayley B., Steven C. (Photo: Business Wire)

Dexcom Warriors from top left to right: Bambi B., Enrrique A., Nenad Š., Qiana D. & Lily D., Nick J. Dexcom Warriors from bottom left to right: Natalie B., Victor G., Patti L., Hayley B., Steven C. (Photo: Business Wire)

To shine a spotlight on the daily battle of living with diabetes, Dexcom unveiled a first-of-its-kind, global portrait gallery that gives an honest but hopeful look at people living with diabetes from all walks of life as they navigate the highs and lows of living with an invisible disease.

Brought to life by creative director, Dexcom Warrior, and Australian model Bambi Northwood-Blyth, and photographed by renowned portrait photographer Fernando Sippel, features Dexcom Warriors from around the world, each living with Type 1 or Type 2 diabetes. Dexcom CGM users whose portraits appear in the gallery include:

• Beth McDaniel and Ellen Watson, Northern Irish best friends and students

• Leontine de Hollander, Netherlands photographer

• Christian Mansell, Australian motorsports racing driver

• MiYeong Kim, Korean author and diabetes activist

• Georgiana Dumitra, Romanian lifestyle and beauty content creator

• Nick Jonas, American multi-platinum recording artist, songwriter, actor and philanthropist

• Jeremy Irvine, English actor

• Patti LaBelle, American legendary GRAMMY-winning artist, actress, author and entrepreneur

• Laura Sabourin, Canadian high school teacher

• Victor Garber, Canadian-American actor and singer

“As a Dexcom Warrior living with diabetes, it’s an honor to bring to life this unfiltered and genuine representation of what life is like for the millions of people living with diabetes globally,” said Northwood-Blyth. “In addition to the powerful imagery, each portrait is paired with a deeply personal narrative that highlights the realities of living with diabetes, and how access to technology like Dexcom CGM can lessen the burden of this disease and greatly improve your quality of life.”

The #SeeDiabetes campaign and portrait gallery reinforces Dexcom’s worldwide commitment to broaden access to critical diabetes technology and is aligned with the theme for World Diabetes Day 2021-23, ‘Access to Diabetes Care.’ Elevating broad awareness for the latest diabetes management technology is an essential part of Dexcom’s ongoing efforts to increase access and reimbursement for CGM around the world.

Since Dexcom’s #SeeDiabetes access and awareness campaign last November, reimbursement coverage for CGM has expanded by 6 million people globally from 8 million to 14 million people with significant coverage expansions in the United States, Canada, France and Japan. In addition, Dexcom has brought previously unavailable CGM systems to market in nearly 20 countries around the world over the last 12 months.1

Despite this significant progress, millions more people with diabetes still face challenges obtaining coverage for the CGM systems they need to manage their condition more confidently. #SeeDiabetes: The Faces of Diabetes Warriors gives people with diabetes a unique platform to continue the global conversation about the need to improve access to critical diabetes care and technology.

“Awareness efforts like #SeeDiabetes, paired with clinical evidence that demonstrates the life-changing benefits of CGM, has led to the expansion of access to CGM for millions more people over the years,” said Dexcom president and CEO Kevin Sayer. “Dexcom is committed to working with healthcare providers, private payors, governments and nonprofit organizations around the world to significantly expand access to CGM for people with all Types of diabetes.”

To get involved in the conversation, Dexcom is asking people to visit and to share their own portrait and story of how diabetes has impacted them or someone they know using the hashtag #SeeDiabetes.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information on Dexcom, visit .

1 Dexcom, data on file, 2023

Category: IR

Dexcom, Dexcom Follow, Dexcom Clarity, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries. ©2023 Dexcom, Inc. All rights reserved.

EN
14/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEXCOM INC.

 PRESS RELEASE

Dexcom Reports First Quarter 2024 Financial Results

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an organic1 basis. U.S. revenue and international revenue both grew 24% on a reported basis and international revenue grew 26% on an organic1 basis, all on a year-over-year basis. GAAP operating income of $101.1 million or 11.0% of revenue, an increase of 460 basis points compared to the first quarter of 2023...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dexcom Inc: 1 director

A director at Dexcom Inc sold 49,633 shares at 138.298USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

 PRESS RELEASE

Dexcom Publishes Annual Sustainability Report

SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its annual Sustainability Report. This report provides updates on key corporate sustainability initiatives that are aligned with Dexcom’s core values and business strategy. “We are always working to advance the interests of our stakeholders, including our global customer base, employees and their families, caregivers, our communities, and our shareholders,” said Kevin Sayer, chairman, president and CEO of Dexcom. “We see an inherent connection betw...

 PRESS RELEASE

Dexcom Schedules First Quarter 2024 Earnings Release and Conference Ca...

SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ:DXCM) today announced that it plans to release its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Management will hold a conference call to review the company's first quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at and will be archived there for future reference. To listen to the conference call, please dial (877) 344-3040 (US/Canada) or (646) 475-1647...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch